Targeting anti-apoptotic Bcl-2 by AT-101 to increase radiation efficacy: data from in vitro and clinical pharmacokinetic studies in head and neck cancer von Zerp, Shuraila F, Stoter, T Rianne, Hoebers, Frank J P, van den Brekel, Michiel W M, Dubbelman, Ria, Kuipers, Gitta K, Lafleur, M Vincent M, Slotman, Ben J, Verheij, Marcel

Volltext

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis von Zerp, Shuraila F, Stoter, Rianne, Kuipers, Gitta, Yang, Dajun, Lippman, Marc E, van Blitterswijk, Wim J, Bartelink, Harry, Rooswinkel, Rogier, Lafleur, Vincent, Verheij, Marcel

Volltext

Radiosensitizing potential of the selective cyclooygenase-2 (COX-2) inhibitor meloxicam on human glioma cells von Bijnsdorp, Irene V, van den Berg, Jaap, Kuipers, Gitta K, Wedekind, Laurine E, Slotman, Ben J, van Rijn, Johannes, Lafleur, M Vincent M, Sminia, Peter

Volltext

Radiosensitization of human glioma cells by cyclooxygenase-2 (COX-2) inhibition: Independent on COX-2 expression and dependent on the COX-2 inhibitor and sequence of administration von Kuipers, Gitta K., Slotman, Ben J., Wedekind, Laurine E., Stoter, T. Rianne, van den Berg, Jaap, Sminia, Peter, Lafleur, M. Vincent M.

Volltext

Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme von SMINIA, Peter, STOTER, T. Rianne, VAN DER VALK, Paul, ELKHUIZEN, Paula H. M, TADEMA, Thea M, KUIPERS, Gitta K, VANDERTOP, W. Peter, LAFLEUR, M. Vincent M, SLOTMAN, Ben J

Volltext

AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis von Zerp, Shuraila F, Stoter, Rianne, Kuipers, Gitta, Yang, Dajun, Lippman, Marc E, van Blitterswijk, Wim J, Bartelink, Harry, Rooswinkel, Rogier, Lafleur, Vincent, Verheij, Marcel

Volltext